Pharma Deals Review, Vol 2009, No 12 (2009)

Font Size:  Small  Medium  Large

Novartis Boosts its Oncology Position

Taskin Ahmed

Abstract


Novartis has acquired the rights to two investigational drugs from Incyte Corp indicated for myelofibrosis, blood disorders and cancer in a deal that could exceed US$1 B.



Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.